Jun. 8, 2020
Relief Therapeutics and NeuroRx Expand Clinical Trial of RLF-100 to All Patients with Critical COVID-19 and Respiratory Failure
Clinical trial expanded to patients treated with both noninvasive and mechanical ventilation in critical COVID-19.